Previous close | 38.65 |
Open | 38.65 |
Bid | 28.89 x 200 |
Ask | 39.77 x 200 |
Day's range | 37.20 - 41.04 |
52-week range | 6.71 - 42.88 |
Volume | |
Avg. volume | 1,134,778 |
Market cap | 2.598B |
Beta (5Y monthly) | 1.13 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Lyra Therapeutics (LYRA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Just because a business does not make any money, does not mean that the stock will go down. Indeed, Alpine Immune...
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Q4 2023 Earnings Call Transcript March 18, 2024 Alpine Immune Sciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, welcome to the Alpine Immune Sciences Fourth Quarter 2023 and Full-Year Earnings […]